Industry

Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

Ono and Vertex have entered into an exclusive collaboration and license agreement for povetacicept in Japan and South Korea Povetacicept is a therapeutic in development for multiple serious B cell-mediated diseases including IgA nephropathy and primary membranous nephropathy Povetacicept is a recombinant fusion protein and a dual antagonist of the BAFF and APRIL cytokines OSAKA, … [Read more…]

NEL Animal Cardiovascular Center Achieves World’s First Surgical Correction of Complex VSD in Canine Patient

ANYANG, South Korea–(BUSINESS WIRE)–#Canine—NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world’s first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This veterinary milestone is highly significant, as it marks the first such case not only … [Read more…]

New Data Show Delve Bio’s Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing

Data Presented at the 2025 American Society for Microbiology Microbe Conference BOSTON–(BUSINESS WIRE)–#biotech—Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data presented at the American Society for Microbiology (ASM) Microbe conference in Los Angeles showing the impact of metagenomic sequencing for transforming infectious disease diagnostics by offering advances compared … [Read more…]

Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting

Corrects the Record Following Latest Attempt By the 1Globe Activist Board to Distort Reality in Transparent Attempt to Mislead Shareholders Notes That on Friday Antiguan Judge Denied the 1Globe Activist Board’s Attempt to Immediately Prevent Prime Success From Voting Sinovac Shares – Which the Board Failed to Disclose to Shareholders HONG KONG–(BUSINESS WIRE)–Prime Success L.P., … [Read more…]

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through a comprehensive portfolio of AI-powered imaging technologies, radiopharmaceuticals, cyclotrons, chemistry systems, and workflow-optimizing software—designed to support personalized, data-driven care across the entire patient journey. At #SNMMI25, the company is proud to introduce LesionID™ Pro with automated zero-click pre-processing,i which aims … [Read more…]

SINOVAC Board of Directors Prevails Against Advantech/Prime’s New York Lawsuit

New York Court Denies Advantech/Prime’s Petition for Emergency Injunctive Relief Clears Legal Hurdle for Dividend Paying Agent to Payout the Special Cash Dividend of US$55.00 Per Common Share on July 7, 2025 BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it has prevailed … [Read more…]

CCS Presents Four Peer-Reviewed Posters at American Diabetes Association’s 85th Scientific Sessions

CCS’s latest evidence-based research reinforces the most innovative and intelligent approaches to improving adherence and outcomes, while reducing the total costs of diabetes care CHICAGO–(BUSINESS WIRE)–CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, will present four peer-reviewed posters at the American Diabetes Association’s (ADA) 85th Scientific … [Read more…]

Purdue Pharma L.P. Receives Court Approval of Disclosure Statement Filed in Connection with its Plan of Reorganization

Plan to deliver more than $7.4 billion of creditor distributions Company to begin creditor vote solicitation process; voting deadline set for September 30, 2025 STAMFORD, Conn.–(BUSINESS WIRE)–Purdue Pharma L.P. (“Purdue”) today announced that the United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”) approved the Company’s disclosure statement for its … [Read more…]

Intelas Marks Next Chapter in Compass One Healthcare’s Healthcare Technology Management (HTM) Evolution

Intelas reflects the organization’s commitment, vision, strategy, and structure for creating value in health systems MOORESVILLE, N.C.–(BUSINESS WIRE)–Compass One Healthcare has announced its signature Healthcare Technology Management (HTM) brand: Intelas. Healthcare is evolving rapidly, and the need for integration, standardization, and scale is growing with it. Intelas exemplifies that and represents the next evolution of … [Read more…]

Archeus Technologies Receives FDA Clearance of Investigational New Drug Application for ART-101 in Development for the Treatment of Prostate Cancer

– Company positioned to initiate multiple Phase 1 clinical trials in 2025 for ART-101 and additional novel radiopharmaceutical assets – MADISON, Wis.–(BUSINESS WIRE)–Archeus Technologies, a company developing radiopharmaceutical therapies for the treatment of patients with cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for … [Read more…]